NCT03638856

Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy

Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Premenopausal Women Underwent to Diagnostic Hysteroscopy: Double-blind, Randomized Placebo-Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 17 (actual)
• Sponsor: Department of Medical Services Ministry of Public Health of Thailand · Other Government
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

Research objective To compare effectiveness of oral Misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy Research hypothesis: Null hypothesis Effectiveness of oral misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy is not different from placebo Alternative hypothesis: : Oral Misoprostal for cervical priming in Premenopausal women underwent to diagnostic hysteroscopy is better than placebo

Detailed description

Research design Randomized double-blinded placebo-controlled trial. The investigators who assess the outcomes and the participants do not know Misoprostal group or control group. The patients are given the random concealed envelop which contains Misoprostal or placebo to take before hysteroscopy. Surgeon and the investigator whom assess patients do not know group allocation.

Conditions

• Abnormal Uterine Bleeding
• Chronic Pelvic Pain
• Infertility, Female

Interventions

Type	Name	Description
DRUG	Misoprostol 200Mcg Tab	patient takes 2 tab of 200 mcg of Misoprostal 3 hr before hysteroscopy

Timeline

• Start date: 2018-09-30
• Primary completion: 2018-12-30
• Completion: 2018-12-30
• First posted: 2018-08-20
• Last updated: 2020-10-22

Locations

1 site across 1 country: Thailand